Harnessing the serotonin system to combat inflammatory diseases

2A Biosciences is pioneering the development of serotonergic anti-inflammatory compounds for ophthalmological and other inflammatory indications. With advanced high-throughput capabilities and robust in vitro and in silico programs for predictive assessments, the team is poised to selectively modulate inflammation and spearhead a novel approach to treating a variety of inflammatory disorders.